Amani Dental Partners: The AI-Native DPO Bet

Most dental platforms launch with a list of acquired practices. Amani Dental Partners launched with a thesis instead: that the hardest problems in a growing dental group are not clinical or even financial, but behavioral — the missed call, the recall that never happens, the schedule full of holes. Built by a team of fintech operators rather than career dentists, Amani is one of the first dental organizations to put artificial intelligence at the center of its model from day one rather than bolting it on after the fact. For an investor mapping where technology meets dental consolidation, Amani is a small but unusually instructive early-stage case.

Overview

Amani Dental Partners (also branded simply "Amani Dental") is a Manhattan Beach, California–based dental organization that launched publicly in January 2026. It positions itself as a "Dental Partnership Organization" (DPO) rather than a traditional Dental Service Organization (DSO) — a distinction it draws sharply, framing control as the thing a DSO sells and support as the thing it sells instead.¹ The name comes from the Swahili word for "peace," a deliberate signal toward the company-reported themes of trust, continuity, and minimal disruption to how a practice already runs.²

What makes Amani distinctive is its founding team. The company was founded by Stefan Sharma, who came to dentistry from New York quantitative finance and previously built two healthcare-finance ventures — MedPut (interest-free credit for healthcare costs) and Basis (a patient-financing platform that uses data beyond FICO scores to lift case acceptance).³ That lineage runs straight into Amani's technology layer, Jaza AI, a "virtual front desk" the founders built to handle patient communication and scheduling in the background.¹ Because the technology and the operating model were designed together rather than acquired separately, Amani describes itself, and is described by trade press, as AI-native.²

A caveat worth fixing early: "Amani" is not a unique brand name in dentistry. An unrelated single-office practice, Amani Dental Studio in Coral Gables, Florida, and a separate registered entity using the Amani Dental name in Loma Linda, California, are different organizations and should not be folded into any read of Amani Dental Partners' footprint or scale.

Company Snapshot

• Founded: Company founded December 2025; public launch January 2026.³
• HQ: Manhattan Beach, California; founder and core team also operate out of Dallas, Texas.²
• Model: Dental Partnership Organization (DPO) — practice-level ownership retained, with an evolving private-credit arm offering debt facilities to scaling DSOs.¹
• Footprint: No publicly disclosed count of owned, supported, or partnered practices as of mid-2026; appears to be early-stage based on available data.²
• Ownership: Founder-led; no outside capital, private equity, or named debt backers disclosed publicly.⁴
• Leadership: Stefan Sharma (Founder & CEO), Natalie Melear (COO), Sagar Shah (CTO).²
• Technology: Jaza AI virtual front desk, built in-house; founder's prior ventures include Basis and MedPut.¹
• Revenue: Undisclosed.

Business Model

Amani's pitch to a practice owner is structured around what the doctor keeps rather than what they give up: clinical autonomy, existing culture and workflows, and the team. In Amani's own framing, the partnership model offers meaningful liquidity and continued ownership at the practice level, plus participation in the broader organization, without the centralized clinical control associated with traditional roll-ups.¹ Operationally, Amani says it focuses on the unglamorous mechanics that quietly drain a practice — scheduling consistency, follow-up workflows, front-office SOPs, missed-call recovery, and recall reactivation — with Jaza AI doing much of that work automatically.¹

The more interesting development for investors is that Amani's public positioning has broadened since launch. The company's own website now leads with a private-credit message: "debt facilities for scaling DSOs," structured for acquisition, de novo expansion, and recapitalization, paired with AI tooling aimed at lifting patient lifetime value and trimming costs.⁵ That is a meaningfully different audience from the solo practice owner the January launch addressed — it speaks to multi-practice groups that already have scale and need growth capital. Read constructively, this looks less like a reversal than a widening of the aperture: Amani appears to be positioning itself as both a partnership home for individual practices and a sector-specialist lender to other groups, with Jaza AI as the connective tissue in both cases. The capital sources behind any such lending are not yet disclosed, which is worth noting for anyone underwriting the model.

Footprint Analysis

This is the thinnest part of the public record, and honesty matters more than a number. As of mid-2026, neither Amani's launch materials, its website, nor independent trade coverage enumerates a single named partner practice or a total location count.² Group Dentistry Now's January 2026 deal roundup recorded Amani's launch but, unlike the entries for established platforms in the same roundup, listed no acquisitions attached to it.² Becker's Dental Review included Amani in its 2026 "DSOs to know" list and described the model and technology but likewise gave no practice count.⁶

The responsible interpretation is that Amani is at or near the starting line in terms of an owned or directly partnered practice network — an early-stage organization whose scale is genuinely undisclosed rather than understated. Its documented HQ is Manhattan Beach, California, with the founding team also working out of Dallas, but there is no published evidence of a geographic practice cluster to analyze yet. For investors, the absence of a footprint is itself the signal: Amani is a model and a technology platform first, and a practice network second — for now.

Technology & Software Ecosystem

Amani's claim to being AI-native rests primarily on Jaza AI. Trade press describes Jaza as one of a set of "AI-native tools" — alongside the founder's earlier Basis and MedPut financing products — that Amani uses to streamline scheduling, patient communication, and financing.⁶ Functionally, Jaza is presented as a virtual front desk: it handles time-consuming patient outreach, follow-up, and schedule-filling in the background, with the stated goal of reducing no-shows and surfacing revenue already sitting inside a practice's existing patient base.¹ Founder materials frame the value not as adding dashboards for staff to babysit but as removing administrative work before it reaches the team.¹

What is substantiated, then, is real and specific: Jaza is an in-house AI product, built by the same team, integrated from the start rather than licensed from a third party. What is not yet substantiated is independent, quantified outcome data — the case-study numbers behind claims like recovered per-location revenue come from the company's own materials and have not been externally verified. Treated that way, "AI-native" reads as a genuine architectural choice rather than empty marketing, but one whose results remain company-reported. Investors comparing Amani to peers should also note that bundling proprietary software with capital is an increasingly common verticalized-lending playbook; Amani's edge will depend on whether Jaza's behavioral analytics actually improve the economics of the practices it touches.

Growth History

Amani's timeline is short by design. Sharma's prior ventures — MedPut (2016–2021) and Basis (2021–2025) — established the founder's behavioral-finance toolkit, and Jaza launched in late 2024 as the AI product that would later anchor the dental model.³ Amani Dental itself was founded in December 2025 and announced its official launch on January 30, 2026, datelined Manhattan Beach.⁴ In the months since, the most visible "growth" has been in positioning — the move from a dentist-facing DPO message toward the additional private-credit and growth-capital framing on the current website.⁵ No acquisition announcements, funding rounds, or named partner practices have surfaced publicly in that window.

Competitive Landscape

Amani is entering a crowded field from an unusual angle. The DPO label and the "doctor keeps equity" promise put it in direct conceptual company with MB2 Dental, the platform that popularized the dental-partnership model at scale. Against the large generalist DSOs — Heartland Dental, Aspen Dental, and PDS Health — Amani is a rounding error on size but is competing on a different axis entirely: technology-first operations rather than nationwide standardization. Its specialty-agnostic, partnership-led pitch also overlaps with newer multi-state platforms such as SALT Dental Partners.

The sharper distinction is the dual identity. A traditional DSO competes for practices to acquire; a lender competes for groups to finance. Amani is feeling its way toward doing both, which is rare and could be a strength — proprietary AI plus capital is a sticky combination — but it also means Amani competes with two different sets of incumbents at once, from a very early stage and without disclosed backing. That is a harder starting position than a single-lane platform faces.

Market Position

Amani's market position today is best described as a credible thesis in search of proof points. The leadership is genuine and identifiable, the technology is real and integrated, and the behavioral-finance framing is differentiated in a sector where most consolidators still compete on scale and procurement leverage. Those are real assets. The open questions are equally real: there is no disclosed practice footprint, no named capital partner, and no externally verified performance data, and the public positioning has shifted enough in its first half-year that the eventual center of gravity — partnership home, sector lender, or software platform — is not yet settled.

For an investor, that combination makes Amani a watch-list name rather than a benchmark. The right lens is the one the founders chose for themselves: whether an AI-native approach to the behavioral mechanics of dentistry can compound into something durable, or whether capital and standardization from larger incumbents prove to be the more decisive advantages.

TMR Take: For operators: If you value keeping your culture and clinical autonomy and are curious about an AI-first front desk, Amani is worth a conversation — but ask hard questions about footprint, references, and exactly how the partnership economics and liquidity work, since the public record is thin. For vendors: Amani is a technology-native buyer that builds its own AI rather than licensing it; partnership opportunities are more likely in capital, integrations, or specialty services than in selling front-office software it already makes in-house. For investors: Treat Amani as an early-stage option on the AI-native dental thesis — differentiated founders and a real product, but undisclosed scale and funding mean the model is still unproven. Watch for the first named partner practices and any disclosed capital provider as the signals that the thesis is converting to a business.

Sources

1. Amani Dental — company website (homepage and "Why Amani" pages).

2. Group Dentistry Now, "DSO Deal Roundup – January 2026"; Amani Dental launch materials.

3. Stefan Sharma — professional profile and venture history (Amani, Jaza, Basis, MedPut).

4. Amani Dental — official launch announcement, January 30, 2026.

5. Amani Dental — company website, current private-credit positioning.

6. Becker's Dental Review, "DSOs to know: 2026."